BRAF and melanoma: Melanoma cells harboring mutations in the B-Raf proto-oncogene serine/threonine kinase (BRAF) gene, which is considered a genetic hallmark of >50% of melanoma, showed higher levels of Cav 3.1 and Cav 3.3 mRNA [112].